Home LiteratureArticle Details
PMID: 9773251 Published · ppublish English Journal Article Review

Heparin-induced thrombocytopenia and thrombosis.

Clinical reviews in allergy & immunology ·Vol. 16 ·No. 3 ·1998-00-00 ·Pages 237-47

Arepally G, Cines DB

Abstract

暂无摘要

MeSH Terms
Antibodies/blood Antibody Specificity Anticoagulants/adverse effects,immunology Enzyme-Linked Immunosorbent Assay Heparin/adverse effects,immunology Humans Platelet Aggregation/immunology Platelet Factor 4/immunology Thrombocytopenia/chemically induced,immunology Thrombosis/chemically induced,immunology
Chemicals
Antibodies Anticoagulants Platelet Factor 4 Heparin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Arepally G
UNM Health Sciences Center, Albuquerque, USA.
Cines D B
References (89)
89 references, click to expand
  1. Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172).
    Thromb Res. 1993 Jul 15;71(2):123-6 PMID: 7689764
  2. Arterial embolism occurring during systemic heparin therapy.
    AMA Arch Surg. 1958 Feb;76(2):219-25; discussion 225-7 PMID: 13497418
  3. Heparin-induced thrombocytopenia.
    Blood Rev. 1988 Jun;2(2):108-14 PMID: 3042056
  4. Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia.
    Am J Hematol. 1995 Sep;50(1):20-5 PMID: 7668220
  5. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4.
    Blood. 1994 Jun 1;83(11):3232-9 PMID: 8193358
  6. A bioluminescent adenosine nucleotide release assay for the diagnosis of heparin-induced thrombocytopenia.
    Thromb Haemost. 1996 Sep;76(3):479 PMID: 8883293
  7. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
    J Clin Invest. 1994 Jan;93(1):81-8 PMID: 8282825
  8. Heparin-induced thrombocytopenia.
    Annu Rev Med. 1989;40:31-44 PMID: 2658755
  9. Plasmapheresis in the management of heparin-associated thrombocytopenia with thrombosis.
    Am J Hematol. 1988 Jul;28(3):204-6 PMID: 2457310
  10. Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216).
    Semin Thromb Hemost. 1985 Jul;11(3):326-9 PMID: 4048956
  11. Arterial thromboembolism in patients receiving systemic heparin therapy: a complication associated with heparin-induced thrombocytopenia.
    J Bone Joint Surg Am. 1977 Dec;59(8):1061-4 PMID: 591536
  12. Heparin-induced thrombocytopenia.
    Br J Haematol. 1995 Mar;89(3):431-9 PMID: 7734342
  13. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay.
    Transfusion. 1994 May;34(5):381-5 PMID: 8191560
  14. Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia.
    J Lab Clin Med. 1984 Apr;103(4):606-12 PMID: 6699475
  15. Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia.
    Blood. 1991 Nov 1;78(9):2194-7 PMID: 1932741
  16. Fc gamma RIIA H/R 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis.
    Blood. 1997 Jan 15;89(2):370-5 PMID: 9002937
  17. A sensitive and specific functional flow cytometric assay for the diagnosis of heparin-induced thrombocytopenia.
    Br J Haematol. 1997 Sep;98(3):648-56 PMID: 9332321
  18. Specific quantification of heparin-dependent antibodies for the diagnosis of heparin-associated thrombocytopenia using an enzyme-linked immunosorbent assay.
    Thromb Res. 1991 Jun 1;62(5):377-87 PMID: 1896958
  19. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia.
    Thromb Haemost. 1992 Jul 6;68(1):95-6 PMID: 1514184
  20. Heparin-associated thrombosis without thrombocytopenia.
    Ann Intern Med. 1983 Nov;99(5):637-8 PMID: 6195949
  21. Heparin-associated thrombocytopenia: the effects of various intravenous IgG preparations on antibody mediated platelet activation--a possible new indication for high dose i.v. IgG.
    Thromb Haemost. 1994 May;71(5):641-5 PMID: 8091393
  22. Effect of aspirin on heparin-induced thrombocytopenia (HIT) in a patient requiring hemodialysis.
    Blut. 1989 Oct;59(4):393-5 PMID: 2790222
  23. Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin.
    Am J Hematol. 1996 Jun;52(2):90-5 PMID: 8638647
  24. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery.
    Circulation. 1997 Mar 4;95(5):1242-6 PMID: 9054855
  25. Hirudin therapy for heparin-associated thrombocytopenia and deep venous thrombosis.
    Am J Hematol. 1993 Aug;43(4):310-1 PMID: 8372814
  26. Usefulness of antiplatelet drugs in the management of heparin-associated thrombocytopenia and thrombosis.
    Ann Vasc Surg. 1991 Nov;5(6):552-5 PMID: 1722991
  27. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia.
    Blood. 1994 Dec 1;84(11):3691-9 PMID: 7949124
  28. Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation.
    J Thorac Cardiovasc Surg. 1984 May;87(5):673-7 PMID: 6717046
  29. Functional effects of human antiplatelet antibodies.
    Semin Thromb Hemost. 1995;21(1):46-59 PMID: 7604291
  30. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
    Semin Thromb Hemost. 1997;23 (2):197-202 PMID: 9200347
  31. Heparin-induced thrombocytopenia and thrombosis: reversal with streptokinase. A case report and review of literature.
    Am J Hematol. 1991 Apr;36(4):275-9 PMID: 2012074
  32. Heparin-induced thrombocytopenia: an improved method of detection based on lumi-aggregometry.
    Br J Haematol. 1995 Sep;91(1):173-7 PMID: 7577628
  33. A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry.
    Br J Haematol. 1996 Dec;95(4):724-31 PMID: 8982052
  34. Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis.
    Am J Clin Pathol. 1997 Jul;108(1):78-82 PMID: 9208982
  35. Characterization of the humoral immune response in heparin-induced thrombocytopenia.
    Am J Hematol. 1997 Mar;54(3):196-201 PMID: 9067497
  36. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.
    N Engl J Med. 1995 May 18;332(20):1330-5 PMID: 7715641
  37. Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations.
    Surg Gynecol Obstet. 1973 Mar;136(3):409-16 PMID: 4688805
  38. Intraoperative urokinase as an alternative to heparin for patients with suspected heparin-induced thrombocytopenia requiring arterial reconstruction: report of a case and review of the literature.
    J Cardiovasc Surg (Torino). 1996 Oct;37(5):463-5 PMID: 8941686
  39. Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis.
    Semin Thromb Hemost. 1995;21(1):106-16 PMID: 7604289
  40. Heparin-induced thrombocytopenia--response to intravenous immunoglobulin in vivo and in vitro.
    Am J Hematol. 1992 Apr;39(4):312-3 PMID: 1553962
  41. The heparin-induced thrombocytopenia syndrome: an update.
    Surgery. 1987 Oct;102(4):763-70 PMID: 2958948
  42. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia.
    Thromb Haemost. 1991 Dec 2;66(6):734-6 PMID: 1796420
  43. Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients.
    Ann Intern Med. 1976 Aug;85(2):155-60 PMID: 942137
  44. Heparin-associated thrombocytopenia.
    N Engl J Med. 1980 Oct 2;303(14):788-95 PMID: 7412786
  45. Evolution of antibodies anti-PF4/heparin in a patient with a history of heparin-induced thrombocytopenia reexposed to heparin.
    Thromb Haemost. 1994 Nov;72(5):783-4 PMID: 7900087
  46. A diagnostic test for heparin-induced thrombocytopenia.
    Blood. 1986 Jan;67(1):27-30 PMID: 3940551
  47. Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass.
    Chest. 1993 Nov;104(5):1436-40 PMID: 8222802
  48. Detection of antibodies interacting with glycosaminoglycan polysulfate in patients treated with heparin or other polysulfated glycosaminoglycans.
    Int Arch Allergy Appl Immunol. 1983;70(2):157-63 PMID: 6218123
  49. Diagnostic and therapeutic strategies of white clot syndrome.
    Am J Surg. 1991 Aug;162(2):175-9 PMID: 1713745
  50. Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution.
    Am J Hematol. 1997 Sep;56(1):12-6 PMID: 9298861
  51. Heparin-related thrombosis despite normal platelet counts in vascular surgery.
    Am J Surg. 1997 Feb;173(2):117-9 PMID: 9074376
  52. Heparin-induced thrombocytopenia: effect of heparin platelet antibody on platelets.
    Br J Haematol. 1981 Dec;49(4):531-40 PMID: 7317283
  53. Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia.
    Blood. 1996 Jul 15;88(2):410-6 PMID: 8695787
  54. Heparin-induced thrombocytopenia and recurrent thromboembolism.
    Am J Hematol. 1980;8(3):325-32 PMID: 6998288
  55. Early onset of immunological heparin-induced thrombocytopenia in acute myocardial infarction.
    Blood Coagul Fibrinolysis. 1997 Jan;8(1):13-5 PMID: 9105632
  56. Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?
    Surgery. 1993 Oct;114(4):705-10 PMID: 7692613
  57. Heparin immune thrombocytopenia: evidence for a heparin-platelet complex as the antigenic determinant.
    J Lab Clin Med. 1978 Jan;91(1):167-75 PMID: 73564
  58. Reexposure to heparin of patients with heparin-associated antibodies.
    J Vasc Surg. 1989 May;9(5):677-81; discussion 681-2 PMID: 2724455
  59. Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia.
    Am J Clin Pathol. 1995 Dec;104(6):648-54 PMID: 8526207
  60. Dextran 40 reduces heparin-mediated platelet aggregation.
    J Surg Res. 1986 Apr;40(4):382-7 PMID: 2422443
  61. Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia.
    J Lab Clin Med. 1997 Sep;130(3):278-84 PMID: 9341987
  62. Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172.
    Ann Thorac Surg. 1996 Mar;61(3):920-4 PMID: 8619718
  63. HEPARIN--A CAUSE OF ARTERIAL EMBOLI?
    Surgery. 1964 Jun;55:803-8 PMID: 14168000
  64. Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin.
    Clin Exp Immunol. 1997 May;108(2):333-9 PMID: 9158107
  65. Single amino acid mutation of Fc gamma receptor is associated with the development of heparin-induced thrombocytopenia.
    Br J Haematol. 1995 Nov;91(3):761-6 PMID: 8555090
  66. Platelet factor 4: production, structure, and physiologic and immunologic action.
    Proc Soc Exp Biol Med. 1991 Nov;198(2):693-702 PMID: 1718005
  67. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
    Thromb Haemost. 1995 Jan;73(1):21-8 PMID: 7740492
  68. Heparin-induced thrombocytopenia: laboratory studies.
    Blood. 1988 Sep;72(3):925-30 PMID: 3416077
  69. Insights into heparin-induced thrombocytopenia.
    Br J Haematol. 1992 Apr;80(4):504-8 PMID: 1533786
  70. Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies.
    Br J Haematol. 1993 Jun;84(2):322-8 PMID: 8398837
  71. Heparin-associated thrombocytopenia: a critical review and pooled analysis.
    Am J Med Sci. 1993 Apr;305(4):208-15 PMID: 8475945
  72. Coumarin-induced skin necrosis following heparin-induced thrombocytopenia and thrombosis. A case report.
    Angiology. 1996 Jul;47(7):725-7 PMID: 8686970
  73. The glycoprotein IIb/IIIa antagonist c7E3 inhibits platelet aggregation in the presence of heparin-associated antibodies.
    J Vasc Surg. 1997 Jan;25(1):124-30 PMID: 9013915
  74. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes.
    J Lab Clin Med. 1996 Oct;128(4):376-83 PMID: 8833886
  75. Heparin-induced skin lesions.
    Br J Haematol. 1996 Feb;92(2):494-7 PMID: 8603024
  76. A 14-year study of heparin-induced thrombocytopenia.
    Am J Med. 1996 Nov;101(5):502-7 PMID: 8948273
  77. The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia.
    Thromb Haemost. 1993 Apr 1;69(4):344-50 PMID: 8497847
  78. Heparin as a cause of thrombus progression. Heparin-associated thrombocytopenia is an important differential diagnosis in paediatric patients even with normal platelet counts.
    Eur J Pediatr. 1996 Jan;155(1):11-4 PMID: 8750802
  79. Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods.
    Blood. 1975 Mar;45(3):395-401 PMID: 1115835
  80. Heparin-induced thrombocytopenia and thrombosis in ischemic stroke.
    Mayo Clin Proc. 1988 Apr;63(4):353-61 PMID: 3280884
  81. Immune endothelial-cell injury in heparin-associated thrombocytopenia.
    N Engl J Med. 1987 Mar 5;316(10):581-9 PMID: 3807952
  82. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia.
    Br J Haematol. 1996 Mar;92(4):954-9 PMID: 8616093
  83. Disseminated intravascular coagulation during heparin therapy.
    Ann Intern Med. 1974 Apr;80(4):477-81 PMID: 4621079
  84. Heparin induced thrombocytopenia causing life-threatening postoperative haemorrhage.
    Br J Clin Pract. 1996 Oct-Nov;50(7):404-5 PMID: 9015918
  85. Heparin-induced thrombocytopenia and recurrent thromboembolism in siblings.
    Am J Hematol. 1985 Apr;18(4):421-3 PMID: 3976652
  86. Heparin-associated thrombocytopenia treatment with low molecular weight heparin.
    Thromb Haemost. 1986 Feb 28;55(1):37-9 PMID: 3705006
  87. An enzyme-linked immunosorbent assay for the evaluation of thrombocytopenia induced by heparin.
    J Lab Clin Med. 1985 May;105(5):554-9 PMID: 3886814
  88. Heparin-associated thrombocytopenia and thrombosis: implications for perioperative management.
    Anesthesiology. 1997 Sep;87(3):667-75 PMID: 9316974
  89. On the role of platelet Fc gamma RIIa phenotype in heparin-induced thrombocytopenia.
    Thromb Haemost. 1995 Dec;74(6):1564-72 PMID: 8772238
Article Info
Journal
Clinical reviews in allergy & immunology
Abbr.
Clin Rev Allergy Immunol
ISSN
1080-0549
DOI
10.1007/BF02737634
Published
1998-00-00
Pages
237-47
Language
English
Region
United States
NLM ID
9504368
Subset
IM
External Links
PubMed source DOI: 10.1007/BF02737634 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2